35-usc-112
15 cases — ← All topics
| Case | Title | Lower Court | Docketed | Status | Flags | Tags | Question Presented |
|---|---|---|---|---|---|---|---|
| 21-1567 | Biogen International GmbH, et al. v. Mylan Pharmaceuticals Inc. | Federal Circuit | 2022-06-15 | Denied | Amici (2) | 35-usc-112 effective-dose efficacy-requirement federal-circuit multiple-sclerosis patent patent-law patent-specification statutory-interpretation written-description | Is 35 U.S.C. § 112's requirement that a patent specification "contain a written description of the invention" met when the specification describes the… |
| 21-7010 | Jabari J. Johnson v. James Johnson | Tenth Circuit | 2022-01-31 | Denied | IFP | 35-usc-112 federal-circuit patent patent-act standing written-description | /. P/tf/hZ/tf /JfA'-Z/ie S/z^/cwe ZZ///Z r//A -f/te AA/ie /Zfz/r z/zscAz/zok / y?#z/ /fs/ye J ? tfp' tf/tfj //fz A/'A'ff'Z Ayi/y/ r/fAf-/5Z /. A/a/m-… |
| 21-757 | Amgen Inc., et al. v. Sanofi, et al. | Federal Circuit | 2021-11-22 | Judgment Issued | CVSGAmici (33)Response RequestedRelisted (4) | 35-usc-112 claim-construction claim-scope enablement enablement-requirement invention-disclosure judicial-review patent patent-law statutory-interpretation undue-experimentation written-description | 1. Whether enablement is "a question of fact to be determined by the jury," Wood v. Underhill, 46 U.S. (5 How.) 1, 4 (1846), as this Court has held, o… |
| 21-413 | Infinity Computer Products, Inc. v. Oki Data Americas, Inc. | Federal Circuit | 2021-09-15 | Denied | Response RequestedResponse WaivedRelisted (2) | 35-usc-112 claim-construction claim-interpretation definiteness-standard expert-testimony indefiniteness patent patent-law patent-specification person-skilled-in-the-art prosecution-history | Whether a patent claim is indefinite under § 112, ¶ 2, if conflicting positions about a claim term arise during the patent prosecution process, even i… |
| 21-170 | Rain Computing, Inc. v. Samsung Electronics America, Inc., et al. | Federal Circuit | 2021-08-05 | Denied | 35-usc-112 35-usc-112f claim-construction federal-circuit indefiniteness nautilus-standard nautilus-v-biosig patent patent-law statutory-interpretation | Whether a patent claim may be invalidated for indefiniteness only if, under 35 U.S.C. § 112, para. 2 (now subsection 112(b)) as construed by Nautilus,… | |
| 20-7267 | Kevin L. Martin v. Cathleen Capron, et al. | Seventh Circuit | 2021-03-01 | Dismissed | Response WaivedIFP | 35-usc-112 court-of-appeals enablement invention patent prior-art | whether thE couat of Arpeal G-) Follew stventh circuit oF constitutional 1bf42ubpend u42ow 4420m Lo4310n Li29 2r6y 452 beFore +yb2 te notice A deal wi… |
| 20-863 | Akeva L.L.C. v. Nike, Inc., et al. | Federal Circuit | 2020-12-30 | Denied | Amici (1)Response WaivedRelisted (2) | 35-usc-112 claim-construction claim-interpretation federal-circuit-split innovation-goals judicial-precedent patent-claim-construction patent-law patent-property-rights predictability property-rights public-notice | Whether the Federal Circuit's "heavy presumption" line of cases or its "holistic" line should govern claim construction. |
| 20-88 | HZNP Finance Limited, et al. v. Actavis Laboratories UT, Inc. | Federal Circuit | 2020-07-29 | Denied | Response RequestedResponse WaivedRelisted (2) | 35-usc-112 claim-construction consisting-essentially-of nautilus-v-biosig patent patent-act patent-claim patent-validity reasonable-certainty statutory-interpretation transitional-phrase | Whether the "basic and novel properties" identified in connection with a patent claim's transitional phrase "consisting essentially of" must independe… |
| 19-8094 | Caleb S. Motupalli v. Andrei Iancu, Director, United States Patent and Trademark Office | Federal Circuit | 2020-03-24 | Denied | Response WaivedIFP | 35-usc-112 america-invents-act enablement interdisciplinary-invention interdisciplinary-team patent-enablement patent-examination patent-specification pre-aia pro-se single-skilled-person waiver | 35 U.S.C. §112 requires that the specification of a patent application describe the invention in such terms that those skilled in the art are enabled … |
| 19-1131 | Actavis Laboratories FL, Inc. v. Nalpropion Pharmaceuticals LLC | Federal Circuit | 2020-03-16 | Denied | Amici (1) | 35-usc-112 claim-construction federal-circuit patent-claims patent-law patent-law-35-usc-112 patent-specification patent-validity statutory-interpretation written-description written-description-requirement | Whether § 112 requires a patent's specification to contain a written description of all of the limitations of a patent's claims, not just a "substanti… |
| 19-1073 | Enzo Life Sciences, Inc. v. Roche Molecular Systems, Inc., et al. | Federal Circuit | 2020-03-02 | Denied | Response Waived | 35-usc-112 35-usc-282 clear-and-convincing-standard enablement inoperability non-enabled-claims patent-law patent-validity presumption-of-validity statutory-interpretation unpredictability | I. In light of a patent's presumption of validity under 35 U.S.C. § 282 and the concomitant clear and convincing standard for proving invalidity, may … |
| 19-584 | Nuvo Pharmaceuticals (Ireland) Designated Activity Company, et al. v. Dr. Reddy's Laboratories Inc., et al. | Federal Circuit | 2019-11-04 | Denied | Response Waived | 35-usc-112 enablement federal-circuit innovation patent patent-law pharmaceutical pharmaceutical-composition prior-art written-description | Whether the Federal Circuit erred by holding that, whenever the prior art teaches away from a pharmaceutical composition, the written description of a… |
| 19-211 | Time Warner Cable, Inc., et al. v. Sprint Communications Company, L.P. | Federal Circuit | 2019-08-19 | Denied | Amici (1) | 35-usc-112 35-usc-112a 35-usc-284 apportionment federal-circuit garretson-v-clark patent-claims patent-damages patent-infringement patent-validity reasonable-royalty written-description | 1. Whether the Federal Circuit erred by affirming a damages award based on unapportioned end-user service revenues. 2. Whether the Federal Circuit er… |
| 18-1515 | Eli Lilly and Company v. Erfindergemeinschaft UroPep GbR | Federal Circuit | 2019-06-06 | Denied | Amici (3)Response RequestedResponse WaivedRelisted (2) | 35-usc-112 ariad-pharmaceuticals claim-construction enablement functional-claiming halliburton-oil-well-cementing halliburton-oil-well-cementing-co-v-walker halliburton-precedent patent-claims patent-eligibility patent-law point-of-novelty single-step-claim written-description | Whether a single-step patent claim that describes its point of novelty solely in functional terms violates the rule against functional claiming set fo… |
| 18-127 | Amgen Inc., et al. v. Sanofi, et al. | Federal Circuit | 2018-07-27 | Denied | Amici (1)Response RequestedRelisted (2) | 35-usc-112 biotechnology enablement federal-circuit innovation patent-law possession statutory-interpretation written-description | Whether the standard for determining the adequacy of the "written description of the invention" should be as the statute says—that the description mus… |